Latest News of INSM
Is Insmed Inc. (INSM) the Best Performing Stock in 2024?
Insmed Inc. (NASDAQ:INSM) is a leading biopharmaceutical company focusing on rare lung diseases. Their innovative therapies show promise, positioning them as a top performer in 2024....
Insmed Inc. (INSM): A Top Mid-Cap Biopharma Stock with Compelling Growth Potential
Insmed Inc. (NASDAQ:INSM) is a top mid-cap growth stock to buy, excelling in biopharmaceutical innovation with positive revenue growth and promising drug development....
Insmed Incorporated (INSM) Surged Following Positive Data For its Drug
The Columbia Acorn Fund's Q2 2024 investor letter discussed the fund's -6.01% return compared to the benchmark's -4.22%, attributing underperformance to disappointing earnings....
-
Insmed Incorporated (INSM): Hedge Funds Are Recommending This Biotech Stock Now
By Yahoo! Finance | 3 weeks agoInsmed Incorporated (NASDAQ:INSM) is a promising biopharmaceutical company in the biotech industry with a strong market presence. Its recent developments and growth potential make it a top choice for ...
-
Insmed (INSM) Rose Due to Positive Trial Results
By Yahoo! Finance | 1 month agoCarillon Tower Advisers released its Q2 2024 investor letter highlighting the Carillon Eagle Small Cap Growth Fund's performance. Small-cap stocks ended the quarter negatively....
-
Insmed Incorporated (NASDAQ:INSM) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year
By Yahoo! Finance | 1 month agoInsmed Incorporated's latest second-quarter results showed a 3.0% share price increase to US$73.98, with revenues exceeding expectations at US$90m. Analysts expect an 8.9% revenue increase in 2024, bu...
-
What Makes Insmed Incorporated (INSM) a Prospective Investment?
By Yahoo! Finance | 2 months agoArtisan Partners' "Artisan Mid Cap Fund" Q2 2024 investor letter reported negative returns, underperforming the index. Notable stock pick Insmed Incorporated (NASDAQ:INSM) showed promising growth pote...
-
Insmed Incorporated (INSM) Stock Price, News, Quote & History
By Yahoo! Finance | 2 months agoInsmed Incorporated is a biopharmaceutical company that focuses on developing and marketing therapies for patients with rare and serious diseases worldwide. Their product portfolio includes ARIKAYCE f...
-
More endpoints met in Insmed's Phase III brensocatib trial
By Yahoo! Finance | 3 months agoInsmed's Phase III ASPEN trial data reveals brensocatib's effectiveness in reducing lung function decline in bronchiectasis patients. Positive results support potential approval as a chronic treatment...